Elevance Health says its acquisition of Verily’s Granular Insurance Company is designed to bolster its offerings to ...

The results beat Wall Street expectations ... Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per share. This story was ...

The recent price dip presents an exceptional buying opportunity, with Wall Street also bullish, averaging a price target of $500.87, a 30% upside. I am updating my analysis on Elevance Health ...

Elevance Health (ELV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Scott Fidel from Stephens downgraded the rating on the stock to a ...

Shares of Elevance Health Inc. ELV shed 1.42% to $385.66 Wednesday, on what proved to be an all-around grim trading session ...

GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...

Elevance Health executives told investors on Thursday morning that they're confident in their 7% to 9% growth targets in Medicare Advantage based on early data coming out of the annual enrollment ...

Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a ...

Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 ...

Verily, an Alphabet (GOOG) (GOOGL) precision health company, has agreed to sell the company’s Granular insurance business to Elevance Health ...

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a ...